Section Reviews: Biologicals & Immunologicals: Pharmacological attenuation of chemotherapy-induced oral mucositis

References to Primarv Literature

• PARKER SL, TONG T, BOLDEN S, WINGO PA: Cancer statistics 1996. Ca-Cancer J. Clin. (1996) 65:5–27.
   Web of Science ®Google Scholar
• JACKS T, WEINBERG RA: Cell cycle control and its watch-man. Nature (1996) 381:643–644.
   PubMed Web of Science ®Google Scholar
• SONIS ST, SONIS AL, LIEBERMAN A: Oral complicationsIn patients receiving treatment for malignancies other than of the head and neck. J. Am. Dent. Assoc. (1978) 97:468–472.
   PubMed Web of Science ®Google Scholar
• PETERSON DE: Pretreatment strategies for infectionprevention in chemotherapy patients. NCI Monograph (1990) 9:61–71.
   PubMedGoogle Scholar
• SONIS ST: Oral complications. Cancer Medicine (2ndEdition). Holland et at. (Eds.). Lea & Febiger (1993):2381–1388.
   Google Scholar
• LOCKHART PB, SONIS ST: Relationship of oral complica-tions to peripheral blood leukocyte and platelet counts In patients receiving cancer chemotherapy. Oral Su. Oral Med. Oral Patbol. (1979) 48(1):21–28.
   PubMedGoogle Scholar
• EORTC INTERNATIONAL ANTIMICROBIAL THERAPY PRO-JECT GROUP: Three antibiotic regimens in the treatment of infection, in febrile granulocytopenic patients with cancer. J. Infect. Dis. (1978) 137:14–29.
   PubMed Web of Science ®Google Scholar
• BERGMANN OJ: Oral infections and septicemia in immu-nocompromised patients with hematologic malignan-cies. J. Clin. Microbiol. (1988) 26:2105–2109.
   PubMed Web of Science ®Google Scholar
• RICHARD P, AMADOR DEL VALLE G, MOREAU F. et al.;Viridans streptococcal bacteremia in patients with neu-tropenia. Lancet (1995) 345:1607–1609.
   Google Scholar
• SONIS ST, TRACEY CA, SHKLAR G, JENSON J, ELORINE D:Animal model for mucositis induced by cancer chemo-therapy. Oral Stag. Oral Med. Oral Pathol. (1990) 60:437–443.
   Google Scholar
• SONIS ST, COSTELLO KA: A database for mucositis in-duced by cancer chemotherapy. Ezir. J. Cancer B Oral Oncol. (1995) 31B(4):258–260.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM D, ZALCBERG JR, RATH U et al.: 'Tomudex'(ZD1604): results of a randomized trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The `Tomudex' Colorectal Cancer Study Group. Eur. J. Cancer (1995) 31A(12):1945–1954.
   PubMed Web of Science ®Google Scholar
• MAKKONEN TA, BOSTROM P, VILJA P, JOENSUU H: Sucral-fate mouth washing in the prevention of radiation-in-duced mucositis: a placebo-controlled double-blind randomized study. Int. J. Radiat. Oncol. Biol. Phys. (1994) 30(1):177–182.
   PubMed Web of Science ®Google Scholar
• EPSTEIN JB, WONG FL: The efficacy of sucralfate suspen-sion in the prevention of oral mucositis due to radiation therapy. Int. J. Radiat. Oncol, Biol. Phys. (1994) 28(3):693–698.
   PubMed Web of Science ®Google Scholar
• FRANZEN L, HENRIKSSON R, LITTBRAND B, ZACKRISSON B: Effects of sucralfate on mucositis during and follow-ing radiotherapy of malignancies in the head and neck region. A double-blind, placebo-controlled study. Ada Oncol. (1995) 34(2):219–223.
   Google Scholar
• SHENEP JL, KALWINSKY DK, HUTSON PR et al.: Efficacy of oral sucralfate suspension in prevention and treat-ment of chemotherapy-induced mucositis. J. Pediatr. (1988) 113(4):758–763.
   PubMed Web of Science ®Google Scholar
• BARKER G, LOFTUS L, CUDDY P, BARKER B: The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Suig. Oral Med. Oral Patbol. (1991 71(3):288–293.
   PubMedGoogle Scholar
• ALLISON RR, VONGTAMA V, VAUGHAN J, SHIN KH: Symp-tomatic acute mucositis can be minimized or prophy-laxed by the combination of sucralfate and fluconazole. Cancer Invest. (1995) 13(1):16–22.
   PubMed Web of Science ®Google Scholar
• BERGER A, HENDERSON M, NADDOLMAN W et al.: Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J. Pain Symptom Management (1995) 20(3):243–248.
   Web of Science ®Google Scholar
• BERGER AM, BARTOSHUK LM, DUFFY VB, NADOOLMAN W: Capsaicht for the treatment of oral mucositis pain. PPO Updates (1995) 9(1):1–11.
   Google Scholar
• SAMARANAYAKE LP, ROBERTSON AG, MACFARLANE TWet al.: The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic Irradiation. Clin. Radio!. (1988) 39(3):291–294.
   Google Scholar
• FOOTE RL, LOPRINZI CL, FRANK AR et al.: Randomizedtrial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J. Clin. Oncol. (1994) 129(12):2630–2633.
   Google Scholar
• EPSTEIN JB, VICKARS L, SPINELLI J, REECE D: Efficacy ofchlorhexidine and nystatin rinses in the prevention of oral complications in leukemia and bone marrow trans-plantation. Oral Surg. Ora/Med. Oral Pathol. (1992) 73:682–689.
   PubMedGoogle Scholar
• WE1SDORF DJ, BOSTROM B, RAETHER D et al,: Oro-pharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant. (1989) 3(5):483–493.
   Google Scholar
• FERRETTI GA, ASH RC, BROWN AT et al.: Control of oral mucositis and candidias is in marrow transplantation: a prospective, double-blind trial of chlorhexidine diglu-conate oral rinse. Bone Marrow Transplant. (1988) 3(5):483–493.
   PubMed Web of Science ®Google Scholar
• SYMONDS RP, THOMAS M, ALCOCK SR et al.: The reduc-tion of radiation mucositis by antibiotic pastilles: a placebo-controlled, double-blind trial [Abstract]. Br. J. Cancer (1995) 72\(Suppl. 25)15.
   Google Scholar
• WADLEIGH RG, REDMAN RS, GRAIIAM ML et al.: VitaminE in the treatment of chemotherapy-induced mucositis. Am. J. Med (1992) 92(5):481–484.
   PubMed Web of Science ®Google Scholar
• OSAKI T, UETA E, YONEDA K, HIROTA J, YAMAMOTO T:Prophylaxis of oral mucositis associated with chemora-diotherapy for oral carcinoma by Azelastine hydrochlo-ride (Azelastine) with other antioxidants. Head Neck (1994) 16(4):331–339.
   PubMed Web of Science ®Google Scholar
• JEBB SA, OSBORNE RJ, MAUGHAN TS et al.: 5-Fluorouraciland folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br. J. Cancer (1994) 70(4):732–735.
   PubMed Web of Science ®Google Scholar
• HANSON WR, AINSWORTH EJ: 16-Dimethyl pro-staglandin E2 induces radioprotection in murine intes-tinal and hematopoietic stem cells. Radiat. Res. (1985) 103:196–203.
   PubMed Web of Science ®Google Scholar
• LABAR B, MRSIC M, PAVLETIC Z et al.: Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant. (1993) 11(5)379–382.
   Google Scholar
• MATEJKA M, NELL A, KMENT G et al.: Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis. Br.J. OralMaxillofacial Stag. (1990) 28(2):89–91.
   PubMed Web of Science ®Google Scholar
• DUENAS-GONZALES A, SOBREVILLA-CALVO P, FRIAS-MENDIVIL M et al.: Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. Bone Marrow Transplant. (1996) 17:809–812.
   PubMed Web of Science ®Google Scholar
• SCHLTBERT MM, NEWTON RE: The use of benzydamineHCI for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. Intl. Tissue React. (1987) 9(2):99–103.
   PubMedGoogle Scholar
• LEVER SA, DUPUIS LL, CHAU HS: Comparative evaluation of benzydamine oral rinse in children with antineo-plastic-induced stomatitis.Clin. Pharm. (1987)21:359–361.
   Google Scholar
• EPSTEIN JB, STEVENSON-MOORE P, JACKSON S, MO-HAMED JII, SPINELLI JJ: Prevention of oral mucositis in radiation therapy: a controlled study with benzyd-amine hydrochloride rinse. Int. J. Radiat. Oncol. Biol. Phys. (1989) 16:1571–1575.
   PubMed Web of Science ®Google Scholar
• LEVEQUE F, FONTANESI J, DEM S et al.: Salivary glandsheltering using concurrent pilocarpine in irradiated head and neck cancer patients. Proc. Am. Soc. Clin. Oncol. (1996). Abstract 1665.
   Google Scholar
• AHMED T, ENGELKING C, SZALYGA J et al.: Propanthelineprevention of mucositis from etoposide. Bone Marrow Transplant. (1993) 12:131–132.
   PubMed Web of Science ®Google Scholar
• BARASCH A, PETERSON D, TANZER J et al.: Helium-neonlaser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer (1995) 76:2550–2556.
   PubMed Web of Science ®Google Scholar
• VERDI CJ: Cancer therapy and oral mucositis. An ap-praisal of drug prophylaxis. Drug Safety (1993) 9(3):185–195.
   PubMed Web of Science ®Google Scholar
• COHEN S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid open-ing in the newborn animaL J. Biol. Chem. (1962) 237:1555–1562.
   Web of Science ®Google Scholar
• STEIDLER NE, READE PC: Histomorphological effects ofepidermal growth factor on skin and oral mucosa in neonatal mice. Arch. Oral Biol. (1980) 25:37–43.
   PubMed Web of Science ®Google Scholar
• SONIS ST, COSTA JW, Jr., EVITTS SM, LINQUIST LE, NICOL-SON M: Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemother-apy. Oral Surg. Oral Med. Oral. Pathol. (1992) 74:749–755.
   Google Scholar
• SONIS A, SONIS S: Oral complications of cancer chemo-therapy in pediatric patients. J. Pedod. (1979) 3(2):122–128.
   PubMedGoogle Scholar
• Thompson Financial Network Report citing Amgen company news release (1996).
   Google Scholar
• SHERR CJ, ROBERTS JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. (1995) 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• COX DA: Transforming growth factor-beta3. Cell Biol. Int. (1995) 19:357–371.
   PubMed Web of Science ®Google Scholar
• SONIS ST, LINDQUIST L, VAN VUGT A et al.: Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res. (1994) 54(5)11135–1138.
   Google Scholar
• MCCORMACK S, HALEY JD, SONIS S, FOULKES JG: Amelioration of oral mucositis by TGF-beta 3 [Abstract]. Proc. Am. Assoc. Cancer Res. (1995) 36:A1706.
   Google Scholar
• SONIS ST et al.: Oral Oncol. (1996). In press.
   Google Scholar
• PIERCE OF, COFFEY RJ: Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine. Am. Sur-geon (1994) 60:18–25.
   PubMed Web of Science ®Google Scholar
• GRZEGORZEWSKI K et al.: Recombinant transforming growth factor f3land132 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J. Exp. Med. (1994) 180:1047–1057.
   PubMed Web of Science ®Google Scholar
• P011EN C: Submitted for publication.
   Google Scholar
• MCCORMACK et al.. Submitted for publication.
   Google Scholar
• KEITH JC JR, ALBERT L, SONIS ST, PFEIFFER CJ, SCHAUB RG: IL-11, a pleiotropic cytokine: exciting new effects of 11–11 on gastrointestinal mucosal biology. Stem Cells (1994) 12\(Suppl. 1):79–90.
   Google Scholar
• SONIS S, MUSKA A, O'BRIEN J et al.: Alteration in the frequency, severity and duration of chemotherapy-in-duced mucositis in hamsters by interleukin-11. Eur. J. Cancer B Oral Oncol. (1995) 31(4)261–266.
   Google Scholar
• BOOTH C, POTTEN CS: Effects of 11-11 on the growth ofintestinal epithelial cells in vitro. Cell Prolif. (1995) 28(11):581–594.
   PubMed Web of Science ®Google Scholar
• GABRILOVE JL, JAKUBOWSKI A, SCHER II et al.: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. New Engl. J. Med. (1988) 318(22):1414–1422.
   PubMed Web of Science ®Google Scholar
• CARTEE L, PETROS WP, ROSNER GL et al.: Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. Cytokine (1995) 7(5)471–477.
   Google Scholar
• GORDON B, SPADINGER A, HODGES E et al.: Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplan-tation. J. Clin. Oncol. (1994) 12(9): 1917–1922.
   PubMed Web of Science ®Google Scholar
• CHI KH, CHEN CH, CHAN WK et al.: Effect of granulocyte-macrophage colony-stimulating factor on oral mucosi-tis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. On-col. (1995) 13(10):2620–2628.
   Google Scholar
• BUI BN, CHEVALL1ER B, CHEVREAU C et al.: Efficacy oflenograstim on hematologic tolerance to MAID chemo-therapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity. J. Clin. Oncol. (1995) 13(10):2629–2636.
   Google Scholar
• CRAWFORD J, GLASPY J, VINCENT M, TOMITA D, MAZANET R: Effect of filgrastim (r-metHug-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxoru-bicin and etoposide, CAE) [Abstract]. Proc. Am. Soc. Clin. Oncol. (1994) 13:A1523.
   Google Scholar
• MCINNES IB et al.: The role of interleukin-15 in T-cellmigration and activation in rheumatoid arthritis. Nature Medicine (1996) 2:175–182.
   PubMed Web of Science ®Google Scholar